Sophia Genetics, a data-driven medicine company that uses AI to help hospitals share diagnostic resources, just raised $77m.
Investment in gene-based medicines and therapies has increased dramatically over the past few years. But, in addition to treating cancer and hereditary illnesses, Sophia Genetics also wants to fix the way that hospitals share medical data.
A problem bigger than any one hospital
Hospitals have a hard time sharing data: As recently as 2015, less than 30% of hospitals were ‘interoperable,’ meaning 70% of hospitals lacked the technology to find and use medical records from other providers.
But Sophia wants to not only help hospitals share medical data, but also pool it together and layer on AI to make diagnoses and predict outcomes.
It’s not their first diagnosis
By analyzing genomic and radiomic data provided by its 850 partner hospitals, Sophia’s AI platform has helped diagnose 300k+ patients in more than 77 countries.
Sophia Genetics has raised a total of $140m since it was founded in 2011, and this new funding will help it expand its US operations via hospital partnerships and hiring.
